uniQure N.V. Other Income
uniQure N.V. (QURE) reported Other Income of $14.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-03-02
- uniQure N.V. other income for the quarter ending 2025-12-31 was $2.00M, a 1.06% increase year-over-year.
- uniQure N.V. other income for the quarter ending 2025-09-30 was $1.51M, a 41.72% decline year-over-year.
- uniQure N.V. other income for the quarter ending 2025-06-30 was $2.60M, a 30.96% increase year-over-year.
- uniQure N.V. other income for the quarter ending 2025-03-31 was $8.31M, a 503.63% increase year-over-year.
- uniQure N.V. other income for fiscal 2025 was $14.41M, a 81.81% increase from fiscal 2024.
- uniQure N.V. other income for fiscal 2024 was $7.93M, a 30.81% increase from fiscal 2023.
- uniQure N.V. other income for fiscal 2023 was $6.06M, a 15.51% decline from fiscal 2022.
- uniQure N.V. other income for fiscal 2022 was $7.17M, a 41.73% decline from fiscal 2021.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.51M derived: sum of 2 quarters · filed 2026-03-02 | $6.10M derived: sum of 3 quarters · filed 2026-03-02 | $14.41M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-10 | $4.11M derived: sum of 2 quarters · filed 2025-11-10 | $12.41M 10-Q · filed 2025-11-10 | $14.39M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-06-30 | $2.60M 10-Q · filed 2025-07-29 | $10.90M 10-Q · filed 2025-07-29 | $12.88M derived: sum of 3 quarters · filed 2026-03-02 | $15.47M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-03-31 | $8.31M 10-Q · filed 2025-05-09 | $10.28M derived: sum of 2 quarters · filed 2026-03-02 | $12.87M derived: sum of 3 quarters · filed 2026-03-02 | $14.86M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $4.57M derived: sum of 2 quarters · filed 2026-03-02 | $6.55M derived: sum of 3 quarters · filed 2026-03-02 | $7.93M 10-K · filed 2026-03-02 |
| 2024-09-30 | $2.59M 10-Q · filed 2025-11-10 | $4.57M derived: sum of 2 quarters · filed 2025-11-10 | $5.95M 10-Q · filed 2025-11-10 | $7.47M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $1.98M 10-Q · filed 2025-07-29 | $3.36M 10-Q · filed 2025-07-29 | $4.88M derived: sum of 3 quarters · filed 2026-03-02 | $6.30M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-09 | $2.90M derived: sum of 2 quarters · filed 2026-03-02 | $4.32M derived: sum of 3 quarters · filed 2026-03-02 | $5.62M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.95M derived: sum of 2 quarters · filed 2026-03-02 | $4.25M derived: sum of 3 quarters · filed 2026-03-02 | $6.06M 10-K · filed 2026-03-02 |
| 2023-09-30 | $1.42M 10-Q · filed 2024-11-05 | $2.73M derived: sum of 2 quarters · filed 2024-11-05 | $4.54M 10-Q · filed 2024-11-05 | $6.73M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-01 | $3.11M 10-Q · filed 2024-08-01 | $5.30M derived: sum of 3 quarters · filed 2025-02-27 | $6.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.81M 10-Q · filed 2024-05-07 | $4.00M derived: sum of 2 quarters · filed 2025-02-27 | $5.49M derived: sum of 3 quarters · filed 2025-02-27 | $8.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.67M derived: sum of 2 quarters · filed 2025-02-27 | $6.86M derived: sum of 3 quarters · filed 2025-02-27 | $7.17M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.49M 10-Q · filed 2023-11-07 | $4.67M derived: sum of 2 quarters · filed 2023-11-07 | $4.98M 10-Q · filed 2023-11-07 | $7.67M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.19M 10-Q · filed 2023-08-01 | $3.50M 10-Q · filed 2023-08-01 | $6.18M derived: sum of 3 quarters · filed 2024-02-28 | $7.86M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $311.00K 10-Q · filed 2023-05-09 | $3.00M derived: sum of 2 quarters · filed 2024-02-28 | $4.67M derived: sum of 3 quarters · filed 2024-02-28 | $12.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.36M derived: sum of 2 quarters · filed 2024-02-28 | $11.95M derived: sum of 3 quarters · filed 2024-02-28 | $12.31M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.68M 10-Q · filed 2022-11-02 | $9.27M derived: sum of 2 quarters · filed 2022-11-02 | $9.62M 10-Q · filed 2022-11-02 | $10.41M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $7.59M 10-Q · filed 2022-08-08 | $7.94M 10-Q · filed 2022-08-08 | $8.73M derived: sum of 3 quarters · filed 2023-02-27 | $9.76M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $352.00K 10-Q · filed 2022-05-02 | $1.14M derived: sum of 2 quarters · filed 2023-02-27 | $2.17M derived: sum of 3 quarters · filed 2023-02-27 | $2.84M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.82M derived: sum of 2 quarters · filed 2023-02-27 | $2.48M derived: sum of 3 quarters · filed 2023-02-27 | $3.34M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.03M 10-Q · filed 2021-10-25 | $1.70M derived: sum of 2 quarters · filed 2021-10-25 | $2.56M 10-Q · filed 2021-10-25 | $3.11M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $669.00K 10-Q · filed 2021-07-26 | $1.53M 10-Q · filed 2021-07-26 | $2.08M derived: sum of 3 quarters · filed 2022-02-25 | $2.54M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $857.00K 10-Q · filed 2021-05-10 | $1.41M derived: sum of 2 quarters · filed 2022-02-25 | $1.87M derived: sum of 3 quarters · filed 2022-02-25 | $2.43M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.01M derived: sum of 2 quarters · filed 2022-02-25 | $1.57M derived: sum of 3 quarters · filed 2022-02-25 | $1.89M 10-K · filed 2022-02-25 |
| 2019-09-30 | $453.00K 10-Q · filed 2020-10-27 | $1.02M derived: sum of 2 quarters · filed 2020-10-27 | $1.33M 10-Q · filed 2020-10-27 | $1.74M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $566.00K 10-Q · filed 2020-07-30 | $879.00K 10-Q · filed 2020-07-30 | $1.29M derived: sum of 3 quarters · filed 2021-03-01 | $1.84M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $313.00K 10-Q · filed 2020-04-29 | $722.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.28M derived: sum of 3 quarters · filed 2021-03-01 | $1.84M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $966.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.53M derived: sum of 3 quarters · filed 2021-03-01 | $2.15M 10-K · filed 2021-03-01 |
| 2018-09-30 | $557.00K 10-Q · filed 2019-10-28 | $1.12M derived: sum of 2 quarters · filed 2019-10-28 | $1.74M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $565.00K 10-Q · filed 2019-07-29 | $1.18M 10-Q · filed 2019-07-29 | ||
| 2017-12-31 | $15.43M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |